Condition

Breast Cancer Stage IV

ClinicalTrials.gov condition label

Clinical trials51

Recruiting16

Common interventions25

Lead sponsors shown15

Clinical trials

51 shown

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced CancerNCT07225309 · 2026-05-01

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term RemissionNCT07459673 · 2026-03-04

Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity ManagementNCT07371585 · 2026-02-18

HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBCNCT06830382 · 2025-10-03

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast CancerNCT06889688 · 2025-02-21

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerNCT06678269 · 2024-11-15

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNCT06268665 · 2024-08-15

HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab GovitecanNCT06236269 · 2024-03-15

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 StudyNCT07030569 · 2024-02-01

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast CancerNCT06246968 · 2024-01-29

A Study of Oral MBQ-167 in Participants With Advanced Breast CancerNCT06075810 · 2023-11-09

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.NCT06064812 · 2023-09-12

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain MetastasesNCT05866432 · 2023-07-01

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · 2023-05-01

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast CancerNCT05377047 · 2022-09-19

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsNCT04150042 · 2021-01-13

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd TherapyNCT06680596 · 2025-07-30

ENROLLING_BY_INVITATION

A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.NCT04469127 · 2024-09-30

Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast CancerNCT06578299 · 2024-08-30

NOT_YET_RECRUITING

Multi-Institutional Transgender & Gender-Diverse Breast Cancer StudyNCT06234488 · 2023-12-08

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or RibociclibNCT05625087 · 2023-10-19

ACTIVE_NOT_RECRUITING

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisNCT05860907 · 2023-10-01

NOT_YET_RECRUITING

Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer PatientsNCT05837533 · 2023-05-17

RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal AntibodyNCT06481553 · 2023-02-01

Study of Dotatate Imaging in Breast CancerNCT05880394 · 2023-01-10

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer PatientsNCT05670054 · 2022-03-01

A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast CancerNCT05190770 · 2021-12-15

Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer.NCT04896320 · 2021-12-15

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer PatientsNCT05033925 · 2021-10-25

Preventing High Blood Sugar in People Being Treated for Metastatic Breast CancerNCT05090358 · 2021-10-08

ACTIVE_NOT_RECRUITING

Sitravatinib in Metastatic Breast CancerNCT04123704 · 2021-09-22

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor CancerNCT05054374 · 2021-09-14

BRaziLian outcomE for metAStatic breasT CancerNCT05559528 · 2021-09-13

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild CardiotoxicityNCT05036252 · 2021-08-27

ACTIVE_NOT_RECRUITING

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor CellsNCT04628806 · 2021-02-17

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.NCT04852081 · 2021-01-01

The Benefit of Surgery in Stage IV of Breast CancerNCT04697043 · 2020-11-20

RWD Study in HER2+ mBC Patients in Third-Line TherapyNCT04566458 · 2020-10-01

Phase II Study of T-DX in HER2-positive Breast Cancer Brain MetastasesNCT04752059 · 2020-07-28

Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast CancerNCT03324425 · 2020-03-04

ACTIVE_NOT_RECRUITING

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer PatientsNCT03870919 · 2019-10-23

ACTIVE_NOT_RECRUITING

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine TherapyNCT04133207 · 2019-01-01

Self-Advocacy Serious Game in Advanced CancerNCT03339765 · 2018-12-13

A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast CancerNCT03045289 · 2018-07-05

The Resistance and Immune Response to Palbociclib in Breast CancerNCT03401359 · 2017-10-24

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer PatientsNCT03032614 · 2017-09-30

PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerNCT03304210 · 2017-09-16

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsNCT03159585 · 2017-04-14

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast CancerNCT03202446 · 2016-06-13

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast CancerNCT02448771 · 2015-07-09

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast CancerNCT00393341 · 2006-10-01

Common interventions

Leading sponsors

Memorial Sloan Kettering Cancer Center8 UNICANCER3 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 Fudan University2 Medical University of Vienna2 SOLTI Breast Cancer Research Group2 Advanced Imaging Projects, LLC1 Baylor Breast Care Center1 Blokhin's Russian Cancer Research Center1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 Charite University, Berlin, Germany1 Dana-Farber Cancer Institute1 Eske Corporation S.A.C1 Exactis Innovation1 Forward Pharmaceuticals Co., Ltd.1

Trial status mix

RECRUITING16

COMPLETED13

UNKNOWN10

ACTIVE_NOT_RECRUITING5

NOT_YET_RECRUITING2

TERMINATED2

WITHDRAWN2

ENROLLING_BY_INVITATION1

Phase mix

PHASE220

PHASE112

NA7

PHASE34

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.